MapLight Therapeutics (MPLT) Share-based Compensation (2024 - 2025)
MapLight Therapeutics' (MPLT) quarterly Share-based Compensation came in at $35.5 million in Q4 2025, up 16498.6% year-on-year from N/an in Q4 2024, and up 28316.8% quarter-over-quarter from $125000.0 in Q3 2025.
MapLight Therapeutics (MPLT) Share-based Compensation (2024 - 2025) Analysis & Trends
MapLight Therapeutics has disclosed Share-based Compensation across 2 years of filings, most recently posting $35.5 million for Q4 2025.
- Share-based Compensation for Q4 2025 came in at $35.5 million, up 16498.6% year-over-year; the trailing twelve-month figure through Dec 2025 was $36.2 million (changed N/A YoY), and the FY2025 annual result was $36.0 million, up 3233.89% from the prior year.
- Share-based Compensation came in at $35.5 million for Q4 2025 at MapLight Therapeutics, up from $125000.0 in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $35.5 million in Q4 2025 to a low of $125000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 305,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 166.40 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 26.47 Mn |
| 10 | MapLight Therapeutics | 248.88 Mn | 248.88 Mn | - | 35.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 35.52 Mn |
| Dec 31, 2025 | 35.52 Mn |
| Sep 30, 2025 | 125,000.00 |
| Sep 30, 2025 | 125,000.00 |
| Dec 31, 2024 | 214,000.00 |
| Dec 31, 2024 | 214,000.00 |
| Sep 30, 2024 | 354,000.00 |
| Sep 30, 2024 | 354,000.00 |